Osborne Partners Capital Management LLC boosted its stake in Danaher Corporation (NYSE:DHR) by 0.8% during the second quarter, Holdings Channel reports. The fund owned 184,408 shares of the conglomerate’s stock after buying an additional 1,432 shares during the period. Danaher Corporation accounts for about 2.2% of Osborne Partners Capital Management LLC’s holdings, making the stock its 7th largest position. Osborne Partners Capital Management LLC’s holdings in Danaher Corporation were worth $15,562,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of DHR. Peddock Capital Advisors LLC boosted its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. Proficio Capital Partners LLC boosted its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares during the last quarter. ClariVest Asset Management LLC purchased a new stake in shares of Danaher Corporation during the first quarter valued at approximately $157,000. Motco boosted its stake in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares during the last quarter. Finally, Baystate Wealth Management LLC boosted its stake in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.

Shares of Danaher Corporation (NYSE DHR) traded up 0.67% during trading on Friday, hitting $79.82. The stock had a trading volume of 2,433,944 shares. The stock’s 50 day moving average is $82.89 and its 200-day moving average is $84.21. The company has a market cap of $55.45 billion, a PE ratio of 25.48 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.

Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter last year, the firm earned $0.90 earnings per share. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/12/danaher-corporation-nysedhr-stake-boosted-by-osborne-partners-capital-management-llc.html.

DHR has been the subject of several research reports. Deutsche Bank AG reiterated a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research report on Wednesday, June 21st. Credit Suisse Group reissued a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. BTIG Research reissued a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research note on Sunday, April 23rd. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Finally, Zacks Investment Research raised Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective on the stock in a research note on Friday, July 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $91.76.

In other Danaher Corporation news, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at $3,283,923.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the transaction, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock worth $3,206,426 in the last quarter. 12.20% of the stock is owned by insiders.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.